Compounds > lutetium
Page last updated: 2024-08-22

lutetium and Colorectal Neoplasms

lutetium has been researched along with Colorectal Neoplasms in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's1 (9.09)29.6817
2010's9 (81.82)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bawa, O; Berthier-Vergnes, O; Besse, S; Bonnet, M; Boucheix, C; Briat, A; Chezal, JM; Degoul, F; Fois, G; Maigne, L; Maisonial-Besset, A; Miot-Noirault, E; Navarro-Teulon, I; Opolon, P; Pichard, A; Pouget, JP; Quintana, M; Rubinstein, E; Witkowski, T; Zhu, Y1
Cook, BE; Fung, K; Lewis, JS; Membreno, R; Zeglis, BM1
Haylock, AK; Lundqvist, H; Mortensen, AC; Nestor, M; Spiegelberg, D1
Boerman, OC; Chang, CH; Goldenberg, DM; McBride, WJ; Oyen, WJ; Rossi, EA; Schoffelen, R; Sharkey, RM; van der Graaf, WT; Visser, EP; Woliner-van der Weg, W1
Carrasquillo, JA; Chalasani, S; Cheal, SM; Cheung, NV; Fung, EK; Guo, HF; Jungbluth, A; Larson, SM; Lee, SG; O'Donoghue, J; Punzalan, B; Smith-Jones, PM; Wittrup, KD; Xu, H; Zanzonico, PB1
Bleichrodt, R; Boerman, O; de Jong, G; Franssen, G; Hendriks, T; Oyen, W1
Bleichrodt, RP; Boerman, OC; de Jong, GM; Eek, A; Hendriks, T; Nagtegaal, ID; Oyen, WJ1
Bleichrodt, RP; Boerman, OC; de Jong, GM; Eek, A; Hendriks, T; Oyen, WJ1
Kjaer, A; Madsen, J; Persson, M; Ploug, M; Rasmussen, P1
Bleichrodt, RP; Boerman, OC; Goldenberg, DM; Koppe, MJ; Oyen, WJ; Soede, AC; Verhofstad, AA1
Brechbiel, MW; Buchsbaum, DJ; Chappell, LL; Khazaeli, MB; Mayo, MS; Rogers, BE1

Trials

1 trial(s) available for lutetium and Colorectal Neoplasms

ArticleYear
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:8

    Topics: Adult; Aged; Antibodies, Bispecific; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Haptens; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Lutetium; Male; Middle Aged; Oligopeptides; Precision Medicine; Radiation Dosage; Radioimmunotherapy; Radiometry; Tomography, Emission-Computed, Single-Photon

2014

Other Studies

10 other study(ies) available for lutetium and Colorectal Neoplasms

ArticleYear
Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer.
    Oncotarget, 2017, Mar-28, Volume: 8, Issue:13

    Topics: Animals; Antibodies, Monoclonal; Colorectal Neoplasms; Female; Humans; Immunoconjugates; Indium Radioisotopes; Lutetium; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Radioimmunotherapy; Radiopharmaceuticals; Tetraspanins; Tissue Distribution; Xenograft Model Antitumor Assays

2017
Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma.
    Molecular pharmaceutics, 2018, 04-02, Volume: 15, Issue:4

    Topics: Animals; Antibodies; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Humans; Immunoconjugates; Isotope Labeling; Lutetium; Mice; Positron-Emission Tomography; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Tissue Distribution

2018
Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.
    International journal of oncology, 2018, Volume: 52, Issue:6

    Topics: Animals; Antibodies, Monoclonal; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; HCT116 Cells; Humans; Hyaluronan Receptors; Iodine Radioisotopes; Lutetium; Mice; Mice, Nude; Protein Engineering; Radioimmunotherapy; Radioisotopes; Radiometry; Recombinant Proteins; Xenograft Model Antitumor Assays

2018
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:5

    Topics: Animals; Antibodies, Bispecific; Antibody Affinity; Colorectal Neoplasms; Immunoconjugates; Immunoglobulin G; Lutetium; Membrane Glycoproteins; Mice; Radioimmunotherapy; Radiopharmaceuticals; Single-Chain Antibodies; Xenograft Model Antitumor Assays; Yttrium Radioisotopes

2016
Adjuvant radioimmunotherapy after radiofrequency ablation of colorectal liver metastases in an experimental model.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2011, Volume: 37, Issue:3

    Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Liver Neoplasms; Lutetium; Male; Octreotide; Positron-Emission Tomography; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Rats; Reproducibility of Results; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed; Triiodobenzoic Acids

2011
Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases.
    Annals of surgery, 2011, Volume: 253, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Colorectal Neoplasms; Hepatectomy; Indium Radioisotopes; Liver Neoplasms; Lutetium; Male; Neoplasm Recurrence, Local; Radioimmunotherapy; Radioisotopes; Radiotherapy, Adjuvant; Rats; Rats, Inbred Strains; Survival Rate

2011
Experimental study of radioimmunotherapy versus chemotherapy for colorectal cancer.
    The British journal of surgery, 2011, Volume: 98, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Lutetium; Male; Neoplasm Transplantation; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rats; Tumor Cells, Cultured

2011
New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:7

    Topics: Animals; Beta Particles; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dideoxynucleosides; Female; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Lutetium; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Oligopeptides; Positron-Emission Tomography; Radioisotopes; Receptors, Urokinase Plasminogen Activator; Substrate Specificity

2012
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Colorectal Neoplasms; Injections, Intraperitoneal; Injections, Intravenous; Iodine Radioisotopes; Lutetium; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Organ Specificity; Peritoneal Neoplasms; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Rhenium; Sensitivity and Specificity; Tissue Distribution; Yttrium Radioisotopes

2004
Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA).
    Bioorganic & medicinal chemistry, 1999, Volume: 7, Issue:11

    Topics: Aniline Compounds; Animals; Chelating Agents; Colorectal Neoplasms; Cross-Linking Reagents; Disease Models, Animal; Heterocyclic Compounds; Humans; Lutetium; Mice; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy

1999